Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nefopam for post-caesarean pain management
PACTR202509752510761Phase 3Not yet recruiting
- Sponsor
- Maria Bassey
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nefopam and diclofenac in postoperative pain (2 arms), sponsored by Maria Bassey. Primary endpoint: Pain intensity. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
nefopamdiclofenac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202509752510761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202509752510761.